Scienture Holdings, Inc. (SCNX) Latest Filing Signal

Latest Filing: 10-K  |  Filed Mar 30, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for Scienture Holdings, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, Scienture Holdings, Inc.'s filing signal continuing negative.
earningsVibe SuperAnalyst™ Verdict: CONTINUING NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Turned Positive
GEMINI
Turned Positive
CLAUDE
Continuing Negative
CHATGPT
Turned Positive

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does Scienture Holdings, Inc. actually do?
Answer:
Scienture Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing products for cardiovascular and central nervous system diseases. The company launched its first commercial product, ARBLI (losartan potassium) Oral Suspension, in the third quarter of 2025 for hypertension, and is commercializing REZENOPY (naloxone HCl nasal spray) for opioid overdose. Its pipeline includes candidates for migraine, thrombosis, and pain management, with SCN-104 (dihydroergotamine mesylate injection pen) and SCN-107 (bupivacaine long-acting injection) in development. Scienture LLC, its primary operating subsidiary, aims to address unmet medical needs through innovative technology-based products.
Question:
What are Scienture Holdings, Inc.'s revenue drivers?
Answer:
Revenue is primarily driven by the sales of its commercialized pharmaceutical products, ARBLI and REZENOPY. The company expects future revenue growth from its development pipeline.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required